Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 07:16 PM EDT
Marker Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.78M | -10.73M | -9.63M | -10.31M | -11.47M | -14.05M | -15.16M | -17.91M | -23.79M | -28.74M | -34.64M | -41.35M | -43.01M | -41.88M | -40.62M | -35.56M | -31M |
Depreciation & Amortization | n/a | n/a | -971.73K | -971.73K | -971.73K | n/a | 1.94M | 2.98M | 3.82M | 3.68M | 3.54M | 3.3M | 3.24M | 3.16M | 2.81M | 2.39M | 1.75M |
Stock-Based Compensation | 545.59K | 245.86K | 338.69K | 460.43K | 277.77K | 858.27K | 1.43M | 2.19M | 2.67M | 3.64M | 4.39M | 4.92M | 6.22M | 5.96M | 5.75M | 5.55M | 5.26M |
Other Working Capital | 904.57K | n/a | -900.53K | -972.7K | 2.45M | 1.05M | 388.48K | -2.83M | 1.03M | 2.5M | 809.62K | 3.75M | -3.33M | -2.48M | -4.61M | -4.31M | -4.39M |
Other Non-Cash Items | -424.87K | 273.68K | 1.13M | 375.34K | -6.37M | -4.54M | -10.29M | -10.74M | 112.56K | 4.83M | 16.12M | 16.26M | 12.84M | 10.91M | 9.01M | 8.88M | 9.77M |
Deferred Income Tax | n/a | n/a | 2.53M | 2.53M | 2.53M | n/a | 3.28M | 3.28M | -826.58K | 1.71M | -9.58M | -9.58M | -5.47M | -5.47M | -3.57M | -3.57M | -3.57M |
Change in Working Capital | 607.66K | -916.05K | 292.11K | -729.35K | 3.88M | 2.85M | -1.58M | -3.69M | -750.09K | -2.98M | 3.77M | 7.59M | 3.1M | 5.47M | 3.42M | 1.26M | 170.77K |
Operating Cash Flow | -12.57M | -10.91M | -8.57M | -10.9M | -14.39M | -16.44M | -20.38M | -26.9M | -20.63M | -26.97M | -25.52M | -24.39M | -30.45M | -27.28M | -28.64M | -26.36M | -23.82M |
Capital Expenditures | n/a | n/a | n/a | n/a | 112.61K | n/a | -127.34K | -226.71K | -2.61M | -4.95M | -5.17M | -7.07M | -5.14M | -3.13M | -6.17M | -7.28M | -10.77M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -18.66M | n/a | 18.66M | 18.55M | 37.09M | 18.32M | -2.61M | -4.12M | -5.55M | -5.45M | -3.18M | -1.56M | -6.79M | -6.79M | -6.79M |
Investing Cash Flow | n/a | n/a | -18.66M | n/a | 18.78M | 18.66M | 37.2M | 18.44M | -2.61M | -4.95M | -5.17M | -7.07M | -5.14M | -3.13M | -6.17M | -7.28M | -10.77M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.57K | 62.16K | 63.64K | 146.54K | 139.57K | 90.48K | 85.34K | 736.00 | n/a | n/a | n/a | n/a | 3.09K | 3.09K | 3.09K | 3.09K | n/a |
Financial Cash Flow | 14.94M | 14.99M | 100.54K | 578.11K | 534.24K | 1.11M | 1.24M | 759.27K | 822.1K | 202.13K | 63.57K | 63.57K | -100.74K | 52.56M | 56.56M | 58.74M | 58.84M |
Net Cash Flow | 2.37M | 4.08M | -8.47M | -10.32M | 4.92M | 3.33M | -602.48K | -7.7M | -22.42M | -31.72M | -30.63M | -31.4M | -35.69M | 22.14M | 21.75M | 25.1M | 24.25M |
Free Cash Flow | -12.57M | -10.91M | -8.57M | -10.9M | -14.28M | -16.44M | -20.51M | -27.12M | -23.24M | -31.92M | -30.69M | -31.46M | -35.59M | -30.41M | -34.81M | -33.64M | -34.59M |